메뉴 건너뛰기




Volumn 75, Issue 4, 2015, Pages 683-690

Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: A randomized phase II study

Author keywords

Capecitabine; Cisplatin; Gemcitabine; Irinotecan; Oxaliplatin; Pancreatic cancer

Indexed keywords

CAPECITABINE; GEMCITABINE; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; FLUOROURACIL; PLATINUM COMPLEX;

EID: 84925493902     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-015-2683-1     Document Type: Article
Times cited : (22)

References (25)
  • 2
    • 77949264996 scopus 로고    scopus 로고
    • Advanced pancreatic carcinoma: Current treatment and future challenges
    • 1:CAS:528:DC%2BC3cXisFemsbo%3D 20101258
    • Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7(3):163-172
    • (2010) Nat Rev Clin Oncol , vol.7 , Issue.3 , pp. 163-172
    • Stathis, A.1    Moore, M.J.2
  • 3
    • 77951755278 scopus 로고    scopus 로고
    • Pancreatic cancer
    • 1:CAS:528:DC%2BC3cXlsV2ns7o%3D 20427809
    • Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605-1617
    • (2010) N Engl J Med , vol.362 , Issue.17 , pp. 1605-1617
    • Hidalgo, M.1
  • 5
    • 20644464360 scopus 로고    scopus 로고
    • Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial
    • 1:CAS:528:DC%2BD2MXlsVyhsrg%3D 15908661
    • Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C, de Gramont A (2005) Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol 23(15):3509-3516
    • (2005) J Clin Oncol , vol.23 , Issue.15 , pp. 3509-3516
    • Louvet, C.1    Labianca, R.2    Hammel, P.3    Lledo, G.4    Zampino, M.G.5    André, T.6    Zaniboni, A.7    Ducreux, M.8    Aitini, E.9    Taïeb, J.10    Faroux, R.11    Lepere, C.12    De Gramont, A.13
  • 6
    • 34948888231 scopus 로고    scopus 로고
    • Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: Pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study
    • Heinemann V, Labianca R, Hinke A, Louvet C (2007) Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study. Ann Oncol 10:1652-1659
    • (2007) Ann Oncol , vol.10 , pp. 1652-1659
    • Heinemann, V.1    Labianca, R.2    Hinke, A.3    Louvet, C.4
  • 8
    • 0037099604 scopus 로고    scopus 로고
    • Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer
    • 1:CAS:528:DC%2BD38XmtVCrtbs%3D 12118027
    • Maisey N, Chau I, Cunningham D, Norman A, Seymour M, Hickish T, Iveson T, O'Brien M, Tebbutt N, Harrington A, Hill M (2002) Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer. J Clin Oncol 20(14):3130-3136
    • (2002) J Clin Oncol , vol.20 , Issue.14 , pp. 3130-3136
    • Maisey, N.1    Chau, I.2    Cunningham, D.3    Norman, A.4    Seymour, M.5    Hickish, T.6    Iveson, T.7    O'Brien, M.8    Tebbutt, N.9    Harrington, A.10    Hill, M.11
  • 10
    • 34250180939 scopus 로고    scopus 로고
    • Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
    • Swiss Group for Clinical Cancer Research Central European Cooperative Oncology Group 10.1200/JCO.2006.09.0886 1:CAS:528:DC%2BD2sXnsVShtbw%3D 17538165
    • Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Saletti P, Bauer J, Figer A, Pestalozzi B, Köhne CH, Mingrone W, Stemmer SM, Tàmas K, Kornek GV, Koeberle D, Cina S, Bernhard J, Dietrich D, Scheithauer W, Swiss Group for Clinical Cancer Research, Central European Cooperative Oncology Group (2007) Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 25(16):2212-2217
    • (2007) J Clin Oncol , vol.25 , Issue.16 , pp. 2212-2217
    • Herrmann, R.1    Bodoky, G.2    Ruhstaller, T.3    Glimelius, B.4    Bajetta, E.5    Schüller, J.6    Saletti, P.7    Bauer, J.8    Figer, A.9    Pestalozzi, B.10    Köhne, C.H.11    Mingrone, W.12    Stemmer, S.M.13    Tàmas, K.14    Kornek, G.V.15    Koeberle, D.16    Cina, S.17    Bernhard, J.18    Dietrich, D.19    Scheithauer, W.20    more..
  • 12
    • 53049086773 scopus 로고    scopus 로고
    • Phase i study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies
    • 1:STN:280:DC%2BD1cnhslKruw%3D%3D 18534963
    • Tan BR, Brenner WS, Picus J, Marsh S, Gao F, Fournier C, Fracasso PM, James J, Yen-Revollo JL, McLeod HL (2008) Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies. Ann Oncol 19(10):1742-1748
    • (2008) Ann Oncol , vol.19 , Issue.10 , pp. 1742-1748
    • Tan, B.R.1    Brenner, W.S.2    Picus, J.3    Marsh, S.4    Gao, F.5    Fournier, C.6    Fracasso, P.M.7    James, J.8    Yen-Revollo, J.L.9    McLeod, H.L.10
  • 16
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
    • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205-216
    • (2000) J Natl Cancer Inst , vol.92 , Issue.3 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3    Wanders, J.4    Kaplan, R.S.5    Rubinstein, L.6    Verweij, J.7    Van Glabbeke, M.8    Van Oosterom, A.T.9    Christian, M.C.10    Gwyther, S.G.11
  • 17
    • 0016725211 scopus 로고
    • The McGill Pain Questionnaire: Major properties and scoring methods
    • 1:STN:280:DyaE2s3htlOhsQ%3D%3D 1235985
    • Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277-299
    • (1975) Pain , vol.1 , pp. 277-299
    • Melzack, R.1
  • 20
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
    • 1:STN:280:DyaK3s7msVarsQ%3D%3D 8433390
    • Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
    • (1993) J Natl Cancer Inst , vol.85 , Issue.5 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3    Bullinger, M.4    Cull, A.5    Duez, N.J.6    Filiberti, A.7    Flechtner, H.8    Fleishman, S.B.9    De Haes, J.C.10
  • 21
    • 0031972496 scopus 로고    scopus 로고
    • Interpreting the significance of changes in health-related quality-of-life scores
    • 1:STN:280:DyaK1c7gtFKrtw%3D%3D 9440735
    • Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139-144
    • (1998) J Clin Oncol , vol.16 , Issue.1 , pp. 139-144
    • Osoba, D.1    Rodrigues, G.2    Myles, J.3    Zee, B.4    Pater, J.5
  • 22
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • 1:STN:280:DyaL1M7ps1SjsQ%3D%3D 2702835
    • Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1-10
    • (1989) Control Clin Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 23
    • 73949107880 scopus 로고    scopus 로고
    • Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment
    • Philip PA, Mooney M, Jaffe D, Eckardt G, Moore M, Meropol N, Emens L, O'Reilly E (2009) Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 27:5660-5669
    • (2009) J Clin Oncol , vol.27 , pp. 5660-5669
    • Philip, P.A.1    Mooney, M.2    Jaffe, D.3    Eckardt, G.4    Moore, M.5    Meropol, N.6    Emens, L.7    O'Reilly, E.8
  • 24
    • 84905650613 scopus 로고    scopus 로고
    • Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomized controlled trials
    • Li Q, Yan H, Liu W, Zhen H, Yang Y, Cao B (2014) Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials. PLoS One 9(8):e104346
    • (2014) PLoS One , vol.9 , Issue.8 , pp. 104346
    • Li, Q.1    Yan, H.2    Liu, W.3    Zhen, H.4    Yang, Y.5    Cao, B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.